Gaps in the prevention of perinatal transmission of hepatitis B virus between recommendations and routine practices in a highly endemic region: a provincial population-based study in China

Table 3 Immunoprophylaxis used in children with HBV infection or resolved infection*

Child**	HBIG (doses)	Vaccination
Child**	HBIG (doses)	Doses	1st	2nd (m)	3rd (m)
Children with positive HBsAg
A	2	3	24 h	1	6
B	2	3	2 m	5	unknown
C	2	3	1 m	2	7
D	0	3	7 d	1	6
E	0	3	24 h	1	6
F	0	3	24 h	1	6
G	0	3	24 h	1	6
H	0	3	24 h	1	6
I	0	3	24 h	1	6
J	0	3	24 h	1	6
K	0	3	24 h	1	6
Children with negative HBsAg and positive anti-HBc
a	2	3	24 h	1	6
b	2	3	24 h	1	6
c	2	3	24 h	1	6
d	1	3	24 h	1	6
e	1	3	24 h	1	6
f	1	3	24 h	1	6
g	1	3	24 h	1	6
h	0	3	24 h	1	6
i	0	3	24 h	1	6
j	0	3	24 h	1	6
k	0	3	24 h	1	6
l	0	3	40 d	2	5
m	0	2	24 h	1	–
n	0	3	24 h	1	6
o	0	3	24 h	1	6
p	0	3	24 h	1	6

*Mothers of children A–K and a–l were positive for both HBsAg and HBeAg, and mothers of children m–p were positive for HBsAg and negative for HBeAg.
**Children a–j and l–n were also positive for anti-HBs, and children k, o, and p were negative for anti-HBs.

ISSN: 1471-2334